Photo by Dalle-E OpenAI

Redsense Medical to Present at Small Cap Growth Virtual Investor Conference

Redsense Medical AB, a Sweden-based medical device innovator focused on monitoring blood leakage during hemodialysis to enhance patient safety, has announced that its CEO, Pontus Nobréus, will be presenting live at the Small Cap Growth Virtual Investor Conference. The conference, hosted by VirtualInvestorConferences.com, will take place on October 12th, 2023.

Investors attending the virtual event will have the opportunity to ask questions to the company in real-time, making it an interactive experience. In case attendees are unable to join the conference live, an archived webcast will be made available after the event. To ensure smooth participation and receive event updates, online investors are encouraged to pre-register and run the online system check.

Redsense Medical AB, a born-global medical device innovator, is dedicated to improving the safety and quality of life for dialysis patients worldwide. With its main market in the United States and sales in Europe and Canada, Redsense promotes patient safety through cost-efficient fiber-optic monitoring of the blood access site during hemodialysis. The Redsense System is designed to immediately detect Venous Needle Dislodgement (VND), a potentially life-threatening complication that causes avoidable deaths.

The Redsense alarm acts as an extra pair of eyes, providing patients, nurses, and caregivers with constant vigilance. The company’s products are used in both clinical and home settings, catering to the increasing popularity of home treatment due to its lower cost, convenience, technological advancements, and political initiatives.

The global population of patients undergoing hemodialysis several times per week due to chronic kidney disease is approaching 4 million, with an estimated annual growth rate of six percent. Every hemodialysis treatment carries the risk of VND, making the Redsense System a crucial tool in ensuring patient safety.

Redsense Medical AB’s shares are listed on the Spotlight Stock Market (REDS) and traded on OTCQX (RDSNF) in the US.

The Small Cap Growth Virtual Investor Conference, organized by VirtualInvestorConferences.com, offers publicly traded companies an interactive platform to present directly to investors. The conference aims to provide a real-time investor engagement solution, allowing companies to connect efficiently with investors, schedule one-on-one meetings, and enhance their presentations with dynamic video content.

For more information about the conference, visit www.virtualinvestorconferences.com.

Contact:
Redsense Medical AB
Pontus Nobréus
CEO
+46 721 711264
pontus.nobreus@redsensemedical.com

Virtual Investor Conferences
John M. Viglotti
SVP Corporate Services, Investor Access
OTC Markets Group
(212) 220-2221
johnv@otcmarkets.com

Leave a comment